用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Acarbose'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页346 条记录, 当前第1/35页。
公开号 公开日 申请号 申请日
1. CN103638031A 2014/3/19 CN20131648249 2013/12/4
专利标题:The preparation method of compound quinatic acid and the application in preparing glycosidase inhibitor 法律状态
专利权人


2. CN103641882A 2014/3/19 CN20131648211 2013/12/4
专利标题:Oleanolic acid and preparation method thereof and the application in preparing glycosidase inhibitor fall in new 2,3 dihydroxyl-30- 法律状态
专利权人


3. CN103641807A 2014/3/19 CN20131726153 2013/12/25
专利标题:A kind of extracting method of apigenin, the pharmaceutical composition that is used for the treatment of diabetes and application thereof 法律状态
专利权人


4. CN103622972A 2014/3/12 CN20131646309 2013/12/4
专利标题:The preparation method of compound 3 α-akebonolic acid and the application in preparing glycosidase inhibitor 法律状态
专利权人


5. CN103613632A 2014/3/5 CN20131648142 2013/12/4
专利标题:Volatile oil acid compounds and preparation method thereof and the application in preparing glycosidase inhibitor fall in new 29- 法律状态
专利权人


6. US20140031282A1 2014/1/30 US13/937010 2013/7/8
专利标题:Formulation for treatment of hyperinsulinemic hypoglycemia following gastric bypass surgery 法律状态
专利权人
An effective combination of 6.25-100 mg of acarbose with a GLP-1 mimetic such as 5-10 mg exenatide or 0.3-3.0 mg liraglutide.


7. CN103520374A 2014/1/22 CN20131433256 2013/9/22
专利标题:A kind of method of extracting alpha-amylase inhibitor from tea fruit skin 法律状态
专利权人


8. CN103505441A 2014/1/15 CN20121226804 2012/6/29
专利标题:Oral solid formulation that comprises biguanides and acarbose and preparation method thereof 法律状态
专利权人


9. CN102210866B 2013/10/16 CN20111148433 2011/6/3
专利标题:Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect 法律状态
专利权人Nankai University;


10. NZ598548A 2013/9/27 NZ20070598548 2007/8/13
专利标题:Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level 法律状态
专利权人NOVARTIS AG;
Abstract - 603255 Disclosed is the compound 2-(3-(cyclopropylmethyl)-2-oxo-imidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of the compound 2-(3-(cyclopropylmethyl)-2-oxoimidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof optionally in combination with a therapeutic...



首页123456下页尾页346 条记录, 当前第1/35页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文